Surface Oncology, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Surface Oncology, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2023.
  • Surface Oncology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2023 was $2.92M, a 88.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $2.92M -$22.5M -88.5% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $23.7M -$2.32M -8.91% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $24.3M -$1.56M -6.04% Dec 31, 2022 10-Q 2023-08-02
Q3 2022 $24.9M -$1.51M -5.71% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $25.5M -$1.45M -5.39% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $26M -$1.4M -5.1% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $25.9M -$2.04M -7.31% Dec 31, 2021 8-K 2023-07-03
Q3 2021 $26.4M -$1.96M -6.91% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $26.9M -$1.93M -6.68% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $27.4M -$1.9M -6.49% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $27.9M +$13.1M +87.9% Dec 31, 2020 10-K 2022-03-02
Q3 2020 $28.4M +$12.5M +79.4% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $28.8M +$12.7M +79.1% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $29.3M +$12.9M +78.9% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $14.9M -$2.14M -12.6% Dec 31, 2019 10-K 2021-03-09
Q3 2019 $15.8M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $16.1M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $16.4M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $17M Dec 31, 2018 10-K 2019-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.